3-(N-tert-Butoxycarbonyl-N-methylamino)aniline, 95.0%, 25g

3-((Benzyloxy)methyl)oxetane, 95.0%, 100mg

3,3'-Di-tert-butyl-2'-((4,8-di-tert-butyl-2,10-dimethoxydibenzo[d,f][1,3,2]dioxaphosphepin-6-yl)oxy)-5,5'-dimethoxy-[1,1'-biphenyl]-2-ol, 97%, 100mg

(S)-3-((tert-Butoxycarbonyl)amino)-4-(o-tolyl)butanoic acid, 98%, 100mg

ETHYL 2-(1-AMINOCYCLOPROPYL)ACETATE, 95.0%, 500mg

(R)-6-METHYLMORPHOLIN-3-ONE, 95%, 1g

1-(4-iso-Butylphenyl)ethanol, 97.0%, 1g

Colonne capillaire GC ROTI®Cap-1, 25 m, 0,25 mm, 0,50 µm, 1 pièce(s)

3-tert-Butylphenylisothiocyanate, 95.0%, 5g

(2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone, 95.0%, 250mg

tert-Butyl 2-(methylsulfonyl)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 250mg

5-Chloromethyl-3-(3-methoxy-phenyl)-[1,2,4]oxadiazole, 95.0%, 1g

tert-Butyl (R)-2-carbamothioylpyrrolidine-1-carboxylate, 97%, 500mg